Enanta Pharmaceuticals
ENTA
#7470
Rank
NZ$0.66 B
Marketcap
NZ$22.94
Share price
-1.46%
Change (1 day)
81.45%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: NZ$0.66 Billion

As of March 2026 Enanta Pharmaceuticals has a market cap of NZ$0.66 Billion. This makes Enanta Pharmaceuticals the world's 7470th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.66 B-20.72%
2025NZ$0.83 B271.8%
2024NZ$0.22 B-27.92%
2023NZ$0.31 B-79.44%
2022NZ$1.52 B-32.12%
2021NZ$2.24 B91.62%
2020NZ$1.17 B-35.53%
2019NZ$1.81 B-11.45%
2018NZ$2.05 B29.87%
2017NZ$1.58 B71.61%
2016NZ$0.92 B1.55%
2015NZ$0.90 B-24.94%
2014NZ$1.20 B102.54%
2013NZ$0.59 B

End of Day market cap according to different sources

On Mar 7th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

NZ$0.66 Billion
by Nasdaq info icon info icon
NZ$0.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$981.57 B 147,343.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$524.42 B 78,674.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$689.36 B 103,450.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$196.56 B 29,426.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$485.04 B 72,758.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$208.02 B 31,147.68%๐Ÿ‡บ๐Ÿ‡ธ USA